Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
Tanja Richter, Thomas E. Mürdter, Georg Heinkele, Jürgen Pleiss, Stephan Tatzel, Matthias Schwab, Michel Eichelbaum and Ulrich M. Zanger
Journal of Pharmacology and Experimental Therapeutics January 2004, 308 (1) 189-197; DOI: https://doi.org/10.1124/jpet.103.056127
Tanja Richter
Thomas E. Mürdter
Georg Heinkele
Jürgen Pleiss
Stephan Tatzel
Matthias Schwab
Michel Eichelbaum
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 308, Issue 1
1 Jan 2004
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
Tanja Richter, Thomas E. Mürdter, Georg Heinkele, Jürgen Pleiss, Stephan Tatzel, Matthias Schwab, Michel Eichelbaum and Ulrich M. Zanger
Journal of Pharmacology and Experimental Therapeutics January 1, 2004, 308 (1) 189-197; DOI: https://doi.org/10.1124/jpet.103.056127
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine
Tanja Richter, Thomas E. Mürdter, Georg Heinkele, Jürgen Pleiss, Stephan Tatzel, Matthias Schwab, Michel Eichelbaum and Ulrich M. Zanger
Journal of Pharmacology and Experimental Therapeutics January 1, 2004, 308 (1) 189-197; DOI: https://doi.org/10.1124/jpet.103.056127
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement